2-naphthol has been researched along with Chronic Kidney Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Baek, CH; Chang, JW; Kim, H; Lee, SK; Yang, WS | 1 |
Chen, Z; Dong, Y; Eckols, TK; Kasembeli, MM; Mitch, WE; Tweardy, DJ; Wang, Y; Zhang, L | 1 |
Gong, R; Ponnusamy, M; Tang, J; Tolbert, E; Yan, Y; Zhao, TC; Zhou, X; Zhuang, S | 1 |
3 other study(ies) available for 2-naphthol and Chronic Kidney Diseases
Article | Year |
---|---|
Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression.
Topics: AMP-Activated Protein Kinases; Animals; Benzamides; Cell Line; Drug Evaluation, Preclinical; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Febuxostat; Heme Oxygenase-1; Humans; Mice; Naphthols; Renal Insufficiency, Chronic; Signal Transduction; Sirtuin 1; Thioredoxins; Tunicamycin; Xanthine Oxidase | 2020 |
Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease.
Topics: Animals; Body Weight; Chromatography, Liquid; Disease Models, Animal; Enzyme Inhibitors; Hand Strength; Muscle, Skeletal; Naphthols; Proteolysis; Rats; Renal Insufficiency, Chronic; STAT3 Transcription Factor; Sulfonamides; Tandem Mass Spectrometry | 2020 |
Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
Topics: Actins; Animals; Benzamides; Carbazoles; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; ErbB Receptors; Fibroblasts; Fibrosis; Furans; Kidney; Male; Mice; Mice, Inbred C57BL; Naphthols; Phosphorylation; Quinolines; Receptor, Platelet-Derived Growth Factor beta; Renal Insufficiency, Chronic; Sirtuin 1; Sirtuin 2; STAT3 Transcription Factor | 2014 |